Presentación    
IMMUNO-RHEUMATOLOGY
Publications
Publications 2014
DOCUMENT I.F. CUARTILE
Márquez, A.; Hernández-Rodríguez, J.; Cid, M. C.; Solans, R.; Castaneda, S.; Fernández-Contreras, M. E.; Ramentol, M.; Morado, I. C.; Narváez, J.; Gómez-Vaquero, C.; Martínez-Taboada, V. M.; Ortego-Centeno, N.; Sopena, B.; Monfort, J.; García-Villanueva, M. J.; Caminal-Montero, L.; de Miguel, E.; Blanco, R.; Palm, O.; Molberg, O.; Latus, J.; Braun, N.; Moosig, F.; Witte, T.; Beretta, L.; Santaniello, A.; Pazzola, G.; Boiardi, L.; Salvarani, C.; González-Gay, M. A.; Martín, J. Influence of the IL17A locus in giant cell arteritis susceptibility. ANNALS OF THE RHEUMATIC DISEASES. 2014; 73(9): 1742-1745. Artículo. 10,377 D1
Fernández-Espartero, C.; de Miguel, E.; Loza, E.; Tomero, E.; Gobbo, M.; Descalzo, M´. A.; Collantes-Estévez, E.; Mulero, J.; Muñoz-Fernández S.; Zarco, P.; Carmona, L. Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. ANNALS OF THE RHEUMATIC DISEASES. 2014; 73(7): 1350-1355. Artículo. 10,377 D1
Dougados, M.; Kissel, K.; Conaghan, P. G.; Mola, E. M.; Schett, G.; Gerli, R.; Hansen, M. S.; Amital, H.; Xavier, R. M.; Troum, O.; Bernasconi, C.; Huizinga, T. W. J. Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study. ANNALS OF THE RHEUMATIC DISEASES. 2014; 73(5): 803-809. Artículo.
10,377
D1
Dougados, M.; Soubrier, M.; Antúnez, A.; Balint, P.; Balsa, A.; Buch, M.H.; Casado, G.; Detert, J.; El-Zorkany, B.; Emery, P.; Hajjaj-Hassouni, N.; Harigai, M.; Luo, S. F.; Kurucz, R.; Maciel, G.; Mola, E. M.; Montecucco, C. M.; McInnes, I.; Radner, H.; Smolen, J. S.; Song, Y. W.; Vonkeman, H. E.; Winthrop, K.; Kay, J. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). ANNALS OF THE RHEUMATIC DISEASES. 2014; 73(1): 62-68. Artículo. 10,377 D1
García-Bermúdez, M.; López-Mejías, R.; Genre, F.; Castaneda, S.; Llorca, J.; González-Juanatey, C.; Corrales, A.; Ubilla, B.; Miranda-Filloy, J.A.; Pina, T.; Gómez-Vaquero, C.; Rodríguez-Rodríguez, L.; Fernández-Gutiérrez, B.; Balsa, A.; Pascual-Salcedo, D.; López-Longo, F. J.; Carreira, P.; Blanco, R.; Martín, J.; González-Gay, M. A. Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis. ARTHRITIS RESEARCH & THERAPY. 2014; 16(4): R146. Artículo. 3,753 Q2
Márquez, A.; Ferreiro-Iglesias, A.; Dávila-Fajardo, C. L.; Montes, A.;
Pascual-Salcedo, D.; Pérez-Pampín, E.; Moreno-Ramos, M. J.; García-
Portales, R.; Navarro, F.; Moreira, V.; Magro, C.; Cáliz, R.; Ferrer, M.
A.; Alegre-Sancho, J. J.; Joven, B.; Carreira, P.; Balsa, A.; Vasilopoulos, Y.; Sarafidou, T.; Cabeza-Barrera, J.; Narváez, J.; Raya, E.; Canete, J. D.; Fernández-Nebro, A.; Ordóñez, M. D.; de la Serna, A. R.; Magallares, B.; Gómez-Reino, J. J.; González, A.; Martín, J. Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis. ARTHRITIS RESEARCH & THERAPY. 2014; 16(2): R66. Artículo.
3,753 Q2
Arroyo-Villa, I.; Bautista-Caro, M. B.; Balsa, A.; Aguado-Acín, P.; Bonilla-Hernán, M. G.; Plasencia, C.; Villalba, A.; Nuno, L.; Puig-Kroger, A.; Martín-Mola, E.; Miranda-Carús, M. E. Constitutively altered frequencies of circulating follicullar helper T cell counterparts and their subsets in rheumatoid arthritis. ARTHRITIS RESEARCH & THERAPY. 2014; 16(6): 500. Artículo. 3,753 Q2
Ferreiro-Iglesias, A.; Calaza, M.; Pérez-Pampín, E.; Longo, F. J. L.; Marenco, J. L.; Blanco, F. J.; Narváez, J.; Navarro, F.; Canete, J. D.; de la Serna, A. R.; González-Álvaro, I.; Herrero-Beaumont, G.; Pablos, J. L.; Balsa, A.; Fernández-Gutiérrez, B.; Caliz, R.; Gómez-Reino, J. J.; González, A. Lack of replication of interactions between polymorphisms
in rheumatoid arthritis susceptibility: case-control study. ARTHRITIS
RESEARCH & THERAPY. 2014; 16(5): 436. Artículo.
3,753 Q2
Márquez, A.; Solans, R.; Hernández-Rodríguez, J.; Cid, M. C.; Castaneda, S.; Ramentol, M.; Morado, I. C.; Rodríguez-Rodríguez, L.; Narváez, J.; Gómez-Vaquero, C.; Miranda-Filloy, J. A.; Martínez-Taboada, V. M.; Ríos, R.; Sopena, B.; Monfort, J.; García-Villanueva, M. J.; Martínez-Zapico, A.; Mari-Alfonso, B.; Sánchez-Martín, J.; Unzurrunzaga, A.; Raya, E. ; de Miguel, E.; Hidalgo-Conde, A.; Blanco, R.; González-Gay, M. A.; Martín, J. Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2014; 32(2 Suppl. 82): S30- S33. Artículo. 2,724 Q2
Samaniego, R.; Palacios, B. S.; Domínguez-Soto, A.; Vidal, C.; Salas, A.; Matsuyama, T.; Sánchez-Torres, C.; de la Torre, I.; Miranda-Carús, M. E.; Sánchez-Mateos, P.; Puig-Kroger, A. Macrophage uptake and accumulation of folates are polarization-dependent in vitro and in vivo and are regulated by activin A. JOURNAL OF LEUKOCYTE BIOLOGY. 2014; 95(5): 797-808. Artículo. 4,289 Q1
Torres, R. J; de Miguel, E.; Bailén, R.; Banegas, J. R.; Puig, J. G. Tubular urate transporter gene polymorphisms differentiate patients with gout who have normal and decreased urinary uric acid excretion. JOURNAL OF RHEUMATOLOGY. 2014; 41(9): 1863-1870. Artículo. 3,187 Q2
López-Mejías, R.; Genre, F.; García-Bermúdez, M.; Ubilla, B.; Castaneda, S.; Llorca, J.; González-Juanatey, C.; Corrales, A.; Miranda-Filloy, J. A.; Pina, T.; Gómez-Vaquero, C.; Rodríguez-Rodríguez, L.; Fernández-Gutiérrez, B.; Balsa, A.; Pascual-Salcedo, D.; López-Longo, F. J.; Carreira, P.; Blanco, R.; Martín, J.; González-Gay, M. A. Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, And EDNRA and carotid intimamedia thickness, carotid plaques, And cardiovascular disease in patients with rheumatoid arthritis. MEDIATORS OF INFLAMMATION. 2014; 756279. Artículo. 3,236 Q2
Emery, P.; Hammoudeh, M.; FitzGerald, O.; Combe, B.; Martín-Mola, E.; Buch, M. H.; Krogulec, M.; Williams, T.; Gaylord, S.; Pedersen, R.; Bukowski, J.; Vlahos, B. Sustained remission with etanercept tapering in early rheumatoid arthritis. NEW ENGLAND JOURNAL OF MEDICINE. 2014; 371(19): 1781-1792. Artículo. 55,873 D1
Bailén, R.; González Senac, N. M.; López, M. M.; Llena, M. L.; Migoya, M.; Rodríguez, M. T.; de Miguel, E.; Torres, R. J.; Puig, J. G. Efficacy and safety of a urate lowering regimen in primary gout. NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS. 2014; 33(4-6): 174-180. Artículo. 1,018 Q4
González-Senac, N. M.; Bailén, R.; Torres, R. J.; de Miguel, E.; Puig, J. G. Metabolic syndrome in primary gout. NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS. 2014; 33(4-6): 185-191. Artículo. 1,018 Q4
Dávila-Fajardo, C. L.; Márquez, A.; Pascual-Salcedo, D.; Ramos, M. J. M.; García-Portales, R.; Magro, C.; Alegre-Sancho, J. J.; Balsa, A.; Cabeza-Barrera, J.; Raya, E.; Martín, J. Confirmation of-174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcome. PHARMACOGENETICS AND GENOMICS. 2014; 24(1): 1-5. Artículo. 3,481 Q1
Bautista-Caro, M. B.; Arroyo-Villa, I.; Castillo-Gallego, C.; de Miguel,
E.; Peiteado, D.; Plasencia-Rodríguez, C.; Villalba, A.; Sánchez-Mateos, P.; Puig-Kroger, A.; Martín-Mola, E.; Miranda-Carús, M. E. Decreased frequencies of circulating follicular helper T cell counterparts and plasmablasts in ankylosing spondylitis patients naive for TNF blockers. PLOS ONE. 2014; 9(9): e107086. Artículo.
3,234 Q1
Genre, F.; López-Mejías, R.; García-Bermúdez, M.; Castañeda, S.; González-Juanatey, C.; Llorca, J.; Corrales, A.; Ubilla, B.; Miranda-Filloy, J.A.; Pina, T.; Gómez-Vaquero, C.; Rodríguez-Rodríguez, L.; Fernández-Gutiérrez, B.; Balsa, A.; Pascual-Salcedo, D.; López-Longo, F. J.; Carreira, P.; Blanco, R.; González-Álvaro, I.; Martín, J.; González-Gay, M. A. Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis. PLOS ONE. 2014; 9(9): e106823. Artículo. 3,234 Q1
Burkhardt, J.; Blume, M.; Petit-Teixeira, E.; Teixeira, V. H.; Steiner, A.;
Quente, E.; Wolfram, G.; Scholz, M.; Pierlot, C.; Migliorini, P.; Bombardieri, S.; Balsa, A.; Westhovens, R.; Barrera, P.; Radstake, T. R. D. J.; Alves, H.; Bardin, T.; Prum, B.; Emmrich, F.; Cornelis, F.; Ahnert, P.; Kirsten, H. Cellular adhesion gene SELP is associated with rheumatoid arthritis and displays differential allelic expression. PLOS ONE. 2014; 9(8): e103872. Artículo.
3,234 Q1
Mola, E. M.; Balsa, A.; Martínez Taboada, V.; Marenco, J. L.; Navarro Sarabia, F.; Gómez-Reino, J.; Álvaro-Gracia, J. M.; Román Ivorra, J. A.; Lojo, L.; Plasencia, C.; Carmona, L. Practice guidelines for the use of subcutaneous abatacept. REUMATOLOGÍA CLÍNICA. 2014; 10(4): 218-226. Article. No Indexado No Indexado
de Miguel, E.; Andreu, J. L.; Naredo, E.; Moller, I. Ultrasound in Rheumatology: where are we and where are we going? REUMATOLOGÍA CLÍNICA. 2014; 10(1): 6-9 sep. Article. No Indexado No Indexado
Tomero, E.; Mulero, J.; de Miguel, E.; Fernández-Espartero, C.; Gobbo, M.; Descalzo, M. A.; Collantes-Estévez, E.; Zarco, P.; Muñoz-Fernández, S.; Carmona, L. Performance of the assessment of Spondyloarthritis International Society criteria for the classification of spondyloarthritis in early spondyloarthritis clinics participating in the ESPERANZA programme. RHEUMATOLOGY. 2014; 53(2): 353-360. Artículo. 4,475 Q1
Abad, M. A.; Ariza, R. A.; Aznar, J. J.; Batlle, E.; Beltrán, E.; Canete, J. D.; de Miguel, E.; Escudero, A.; Fernández-Carballido, C.; Gratacos, J.; Loza, E.; Linares, L. F.; Montilla, C.; Ramos, M. M.; Mulero, J.; Queiro, R.; Raya, E.; Lozano, C. R.; Moreno, J. R.; Sanz, J.; Silva-Fernández, L.; Alonso, J. C. T.; Zarco, P.; Fernández-Sueiro, J. L.; Juanola, X. Standards of care for patients with spondyloarthritis. RHEUMATOLOGY INTERNATIONAL. 2014; 34(2): 165-170. Artículo. 1,516 Q3
Tanaka, Y.; Mola, E. M. IL-6 targeting compared to TNF targeting in
rheumatoid arthritis: studies of olokizumab, sarilumab and sirukumab.
ANNALS OF THE RHEUMATIC DISEASES. 2014; 73(9): 1595-1597. Material Editorial.
10,377 D1
Kneepkens, E. L.; Plasencia, C.; Krieckaert, C. L. M.; Pascual-Salcedo, D.; van der Kleij, D.; Nurmohamed, M. T.; López-Caslá, M. T.; Wieringa, R.; Rispens, T.; Wolbink, G. Golimumab trough levels, Antidrug antibodies and clinical response in patients with rheumatoid arthritis treated in daily clinical practice. ANNALS OF THE RHEUMATIC DISEASES. 2014; 73(12): 2217-2219. Carta 10,377 D1
Murias, S.; Alcobendas, R.; Pascual-Salcedo, D.; Remesal, A.; Peralta, J.; Merino, R. Anti-adalimumab antibodies in paediatric rheumatology patients: a pilot experience. RHEUMATOLOGY. 2014; 53(11): 2124- 2126. Carta 4,475 Q1
Publications 2009 - 2013
YEAR NAME I.F. CUARTILE
2013 Kremer, J.; Li, Z. G.; Hall, S.; Fleischmann, R.; Genovese, M.; Martín-Mola, E.; Isaacs, J. D.; Gruben, D.; Wallenstein, G.; Krishnaswami,
S.; Zwillich, S. H.; Koncz, T.; Riese, R.; Bradley, J. Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis a randomized trial. ANNALS OF INTERNAL MEDICINE. 2013; 159(4): 253-261. Artículo.
16,104 D1
2013 Dougados, M.; Kissel, K.; Sheeran, T.; Tak, P. P.; Conaghan, P. G.; Mola, E. M.; Schett, G.; Amital, H.; Navarro-Sarabia, F.; Hou, A.; Bernasconi, C.; Huizinga, T. W. J. Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY). ANNALS OF THE RHEUMATIC DISEASES. 2013; 72(1): 43-50. Artículo. 9,27 D1
2013 Serrano, A.; Márquez, A.; Mackie, S.L.; Carmona, F. D.; Solans, R.; Miranda-Filloy, J. A.; Hernández-Rodríguez, J.; Cid, M. C.; Castaneda, S.; Morado, I. C.; Narváez, J.; Blanco, R.; Sopena, B.; García-Villanueva, M. J.; Monfort, J.; Ortego-Centeno, N.; Unzurrunzaga, A.; Marí-Alfonso, B.; Sánchez-Martín, J.; de Miguel, E.; Magro, C.; Raya, E.; Braun, N.; Latus, J.; Molberg, O.; Lie, B. A.; Moosig, F.; Witte, T.; Morgan, A. W.; González-Gay, M. A.; Martín, J. Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis. ANNALS OF THE RHEUMATIC DISEASES. 2013; 72(11): 1882-1886. Artículo. 9,27 D1
2013 Aydin, S. Z.; Ash, Z. R.; Tinazzi, I.; Castillo-Gallego, C.; Kwok, C.;
Wilson, C.; Goodfield, M.; Gisondi, P.; Tan, A. L.; Marzo-Ortega,
H.; Emery, P.; Wakefield, R. J.; McGonagle, D. G. The link between
enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. ANNALS OF THE RHEUMATIC DISEASES. 2013; 72(6): 992-995. Artículo.
9,27 D1
2013 Abignano, G.; Aydin, S. Z.; Castillo-Gallego, C.; Liakouli, V.; Woods, D.; Meekings, A.; Wakefield, R. J.; McGonagle, D. G.; Emery, P.; del Galdo, F. Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma. ANNALS OF THE RHEUMATIC DISEASES. 2013; 72(11): 1845-1851. Artículo. 9,27 D1
2013 Mandl, P.; Balint, P. V.; Brault, Y.; Backhaus, M.; d’Agostino, M.A.; Grassi, W.; van der Heijde, D.; de Miguel, E.; Wakefield, R. J.; Logeart, I.; Dougados, M. Clinical and ultrasound-based composite disease activity indices in rheumatoid arthritis: results from a multicenter, randomized study. ARTHRITIS CARE & RESEARCH. 2013; 65(6): 879-887. Artículo. 4,039 Q2
2013 Plasencia, C.; Pascual-Salcedo, D.; García-Carazo, S.; Lojo, L.; Nuno, L.; Villalba, A.; Peiteado, D.; Arribas, F.; Díez, J.; López-Casla, M. T.; Martín-Mola, E.; Balsa, A. The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients. ARTHRITIS RESEARCH & THERAPY. 2013; 15(4): R79. Artículo. 4,117 Q1
2013 Vlagea, A.; Gil, A.; Cuesta, M. V.; Arribas, F.; Díez, J.; Lavilla, P.; Pascual-Salcedo, D. Antiphosphatidylserine/Prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndrome. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS.
2013; 19(3): 289-296. Artículo.
1,575 Q3
2013 Falcao, S.; de Miguel, E.; Castillo-Gallego, C.; Peiteado, D.; Branco,
J.; Mola, E. M. Achilles enthesis ultrasound: the importance of the bursa in spondyloarthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2013; 31(3): 422-427. Artículo.
2,973 Q2
2013 Michou, L.; Cornelis, F.; Barón, M.; Bombardieri, S.; Balsa, A.; Westhovens, R.; Barrera, P.; Alves, H.; Radstake, T. R. D. J.; Migliorini,
P.; Bardin, T.; Petit-Teixeira, E.; Boilard, E. Association study of the platelet collagen receptor glycoprotein VI gene with rheumatoid arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2013; 31(5): 770-772. Artículo.
2,973 Q2
2013 Carmona, L.; Sellas, A.; Rodríguez-Lozano, C.; Juanola, X.; Llorente,
J. F. G.; Sueiro, J. L. F.; Linares, L. F.; de Castro, M. C.; Moreno, M.; Zarco, P.; Ariza, R.; Baraliakos, X.; de Miguel, E. Scoring with the Berlin MRI method for assessment of spinal inflammatory activity in patients with ankylosing spondylitis: a calibration exercise among rheumatologists. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2013; 31(6): 883-888. Artículo.
2,973 Q2
2013 García-Bermúdez, M.; López-Mejías, R.; González-Juanatey, C.; Corrales, A.; Castañeda, S.; Ortiz, A. M.; Miranda-Filloy, J. A.; Gómez-Vaquero, C.; Fernández-Gutiérrez, B.; Balsa, A.; Pascual-Salcedo, D.; Blanco, R.; Llorca, J.; Martín, J.; González-Gay, M. A. CARD8 rs2043211 (p.C10X) polymorphism is not associated with disease susceptibility or cardiovascular events in spanish rheumatoid arthritis patients. DNA AND CELL BIOLOGY. 2013; 32(1): 28-33. Artículo. 1,991 Q3
2013 Gluer, C. C.; Marín, F.; Ringe, J. D.; Hawkins, F.; Moricke, R.; Papaioannu, N.; Farahmand, P.; Minisola, S.; Martínez, G.; Nolla, J. M.; Niedhart, C.; Guanabens, N.; Nuti, R.; Martín-Mola, E.; Thomasius, F.; Kapetanos, G.; Peña, J.; Graeff, C.; Petto, H.; Sanz, B.; Reisinger, A.; Zysset, P. K. Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial. JOURNAL OF BONE AND MINERAL RESEARCH. 2013; 28(6): 1355-1368. Artículo. 6,589 D1
2013 Naredo, E.; Acebes, C.; Brito, E.; de Agustín, J. J.; de Miguel, E.; Mayordomo, L.; Moller, I.; Moragues, C.; Rejón, E.; Rodríguez,
A.; Usón, J.; Garrido, J.; Martínez-Hernández, D. Threedimensional
volumetric ultrasound: a valid method for blinded assessment of response to therapy in rheumatoid arthritis. JOURNAL OF RHEUMATOLOGY. 2013; 40(3): 253-260. Artículo.
3,173 Q2
2013 García-Arias, M.; Pascual-Salcedo, D.; Ramiro, S.; Ueberschlag, M. E.; Jermann, T. M.; Cara, C.; Martín-Mola, E.; Balsa, A. Calprotectin in rheumatoid arthritis association with disease activity in a cross-sectional and a longitudinal cohort. MOLECULAR DIAGNOSIS & THERAPY. 2013; 17(1): 49-56. Artículo. 2,589 Q2
2013 Farahmand, P.; Marín, F.; Hawkins, F.; Moricke, R.; Ringe, J. D.; Gluer, C. C.; Papaioannou, N.; Minisola, S.; Martínez, G.; Nolla, J. M.; Niedhart, C.; Guanabens, N.; Nuti, R.; Martín-Mola, E.; Thomasius, F.; Peña, J.; Graeff, C.; Kapetanos, G.; Petto, H.; Gentzel, A.; Reisinger, A.; Zysset, P. K. Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis. OSTEOPOROSIS INTERNATIONAL. 2013; 24(12): 2971-2981. Artículo. 4,165 Q1
2013 Genin, E.; Coustet, B.; Allanore, Y.; Ito, I.; Teruel, M.; Constantin, A.; Schaeverbeke, T.; Ruyssen-Witrand, A.; Tohma, S.; Cantagrel, A.; Vittecoq, O.; Barnetche, T.; Le Loet, X.; Fardellone, P.; Furukawa, H.; Meyer, O.; Fernández-Gutiérrez, B.; Balsa, A.; González-Gay, M. A.; Chiocchia, G.; Tsuchiya, N.; Martín, J.; Dieude, P. Epistatic interaction between BANK1 and BLK in rheumatoid arthritis: results from a large trans-ethnic metaanalysis. PLOS ONE. 2013; 8 (4): e61044. Artículo. 3,534 Q1
2013 García-Bermúdez, M.; López-Mejías, R.; Genre, F.; Castañeda, S.; González-Juanatey, C.; Llorca, J.; Corrales, A.; Miranda-Filloy, J. A.; Rueda-Gotor, J.; Gómez-Vaquero, C.; Rodríguez-Rodríguez, L.; Fernández-Gutiérrez, B.; Pascual-Salcedo, D.; Balsa, A.; López-Longo, F. J.; Carreira, P.; Blanco, R.; González-Álvaro, I.; Martín, J.; González-Gay, M. A. SMAD3 rs17228212 gene polymorphism is associated with reduced risk to cerebrovascular accidents and subclinical atherosclerosis
in anti-CCP negative Spanish rheumatoid arthritis patients. PLOS ONE. 2013; 8(10): e77695. Artículo.
3,534 Q1
2013 Martín Mola, E.; Balsa, A.; Martínez Taboada, V.; Sanmartí, R.; Marenco, J. L.; Navarro Sarabia, F.; Gómez-Reino, J.; Álvaro-Gracia, J. M.; Román Ivorra, J. A.; Lojo, L.; Plasencia, C.; Carmona, L. Abatacept use in rheumatoid arthritis: evidence review and recommendations. REUMATOLOGÍA CLÍNICA. 2013; 9(1): 5-17. Artículo. No Indexado No Indexado
2013 Bautista-Caro, M. B.; Arroyo-Villa, I.; Castillo-Gallego, C.; de Miguel, E.; Peiteado, D.; Puig-Kroger, A.; Martín-Mola, E.; Miranda-Carús, M. E. Decreased Th17 and Th1 cells in the peripheral blood of patients with early non-radiographic axial spondyloarthritis: a marker of disease activity in HLA-B27(+) patients. RHEUMATOLOGY. 2013; 52(2): 352-362. Artículo. 4,435 Q1
2013 Descalzo, M. A.; García, V. V.; González-Álvaro, I.; Carbonell, J.; Balsa, A.; Sanmartí, R.; Lisbona, P.; Hernández-Barrera, V.; Jiménez-García, R.; Carmona, L. Tackling missing radiographic progression data: multiple imputation technique compared with inverse probability weights and complete case analysis. RHEUMATOLOGY. 2013; 52(2): 331-336. Artículo. 4,435 Q1
2013 Ivorra, J. A. R.; Martínez, J. A.; Lázaro, P.; Navarro, F.; Fernández-
Nebro, A.; de Miguel, E.; Loza, E.; Carmona, L. Qualityof-care standards for early arthritis clinics. RHEUMATOLOGY INTERNATIONAL. 2013; 33(10): 2459-2472. Artículo.
1,627 Q3
2013 García-Bermúdez, M.; López-Mejías, R.; Genre, F.; Castañeda, S.; González-Juanatey, C.; Llorca, J.; Corrales, A.; Miranda-Filloy, J. A.; Pina, T.; Gómez-Vaquero, C.; Rodríguez-Rodríguez, L.; Fernández-Gutiérrez, B.; Pascual-Salcedo, D.; Balsa, A.; López-Longo, F. J.; Carreira, P.; Blanco, R.; González-Álvaro, I.; Martín, J.; González-Gay, M. A. Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis. TISSUE ANTIGENS. 2013; 82(6): 405-409. Artículo. 2,35 Q2
2013 López-Mejías, R.; Genre, F.; García-Bermúdez, M.; Castañeda, S.; González-Juanatey, C.; Llorca, J.; Corrales, A.; Miranda-Filloy, J. A.; Rueda-Gotor, J.; Gómez-Vaquero, C.; Rodríguez-Rodríguez, L.; Fernández-Gutiérrez, B.; Balsa, A.; Pascual-Salcedo, D.; López-Longo, F. J.; Carreira, P.; Blanco, R.; González-Álvaro, I.; Martín, J.; González-Gay, M. A. The 11q23.3 genomic region-rs964184-is associated with cardiovascular disease in patients with rheumatoid arthritis. TISSUE ANTIGENS. 2013; 82(5): 344-347. Artículo. 2,35 Q2
2013 Plasencia, C.; Pascual-Salcedo, D.; Alcocer, P.; Bonilla, M. G.; Villalba, A.; Peiteado, D.; Arribas, F.; Díez, J.; López-Casla, M.T.; Martín-Mola, E.; Balsa, A. The timing of serum infliximab loss, or the appearance of antibodies to infliximab (ATI), is related with the clinical activity in ATI-positive patients with rheumatoid arthritis treated with infliximab. ANNALS OF THE RHEUMATIC DISEASES. 2013; 72(11): 1888-1890. Carta. 9,27 D1
2013 Balsa, A.; Plasencia, C.; Pascual-Salcedo, D. Reply to: understanding
the immunogenicity concept. REUMATOLOGÍA CLÍNICA. 2013; 9(4): 252-253. Carta.
No Indexado No Indexado
2013 Burmester, G. R.; Dougados, M.; Emery, P.; Ferraccioli, G.; Gabay,
C.; Gibofsky, A.; Gómez-Reino, J. J.; Jones, G.; Kvien, T. K.; Murakami, M.; Betteridge, N.; Bingham, C. O.; Bykerk, V.; Choy, E. H.; Combe, B.; Cutolo, M.; Graninger, W.; Lanas, A.; Martín-Mola, E.; Montecucco, C.; Ostergaard, M.; Pavelka, K.; Rubbert-Roth, A.; Sattar, N.; Scholte-Voshaar, M.; Tanaka, Y.; Trauner, M.; Valentini, G.; Winthrop, K. L.; de Wit, M.; van der Heijde, D. Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. ANNALS OF THE RHEUMATIC DISEASES. 2013; 72(4): 482-492. Revisión.
9,27 D1
2013 Dorner, T.; Strand, V.; Castaneda-Hernández, G.; Ferraccioli, G.; Isaacs, J. D.; Kvien, T. K.; Martín-Mola, E.; Mittendorf, T.; Smolen, J. S.; Burmester, G. R. The role of biosimilars in the treatment of rheumatic diseases. ANNALS OF THE RHEUMATIC DISEASES. 2013; 72(3): 322-328. Revisión. 9,27 D1
2012 Plasencia, C.; Pascual-Salcedo, D.; Nuno, L.; Bonilla, G.; Villalba,
A.; Peiteado, D.; Díez, J.; Nagore, D.; del Agua, A. R.; Moral, R.; Martín-Mola, E.; Balsa, A. Infl uence of immunogenicity on the effi cacy of longterm treatment of spondyloarthritis with infl iximab. ANNALS OF THE RHEUMATIC DISEASES. 2012; 71(12): 1955-1960. Article.
9,111 D1
2012 Descalzo, M. A.; Carbonell, J.; González-Álvaro, I.; Sanmartí, R.; Balsa, A.; Hernández-Barrera, V.; Román-Ivorra, J. A.; Ivorra-Cortes, J.; Lisbona, P.; Alperi, M.; Jiménez-García, R.; Carmona, L. Effectiveness of a clinical practice intervention in early rheumatoid arthritis. ARTHRITIS CARE & RESEARCH. 2012; 64(3): 321-330. Article. 3,731 Q2
2012 Tubach, F.; Ravaud, P.; Martín-Mola, E.; Awada, H.; Bellamy,
N.; Bombardier, C.; Felson, D. T.; Hajjaj-Hassouni, N.; Hochberg,
M.; Logeart, I.; Matucci-Cerinic, M.; van de Laar, M.; van der Heijde, D.; Dougados, M. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and
knee osteoarthritis: Results from a prospective multinational study. ARTHRITIS CARE & RESEARCH. 2012; 64(11): 1699-1707. Article.
 3,731  Q2
2012 López-Mejías, R.; García-Bermúdez, M.; González-Juanatey, C.; Castañeda, S.; Miranda-Filloy, J. A.; Gómez-Vaquero, C.; Fernández-Gutiérrez, B.; Balsa, A.; Pascual-Salcedo, D.; Blanco, R.; González-Álvaro, I.; Llorca, J.; Martín, J.; González-Gay, M. A. NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease
in patients with rheumatoid arthritis. ATHEROSCLEROSIS.
2012; 224(2): 426-429. Article.
 3,706 Q1
2012 Serrano, A.; Carmona. F. D.; Miranda-Filloy, J. A.; Castañeda, S.; Rodríguez-Rodríguez, L.; Morado, I. C.; Gómez-Vaquero, C.; Solans, R.; Sopeña, B.; Blanco, R.; Unzurrunzaga, A.; Ortego-Centeno, N.; Marí-Alfonso, B.; de Miguel, E.; Hidalgo-Conde, A.; Martín, J.; González-Gay, M. A. Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the spanish population. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2012; 30(Suppl. 7): s29-s33. Article.  2,655 Q2
2012 García-Bermudez, M.; González-Juanatey, C.; López-Mejías, R.; Rodríguez-Rodríguez, L.; Pérez-Esteban, S.; Castañeda, S.; Urcelay, E.; Miranda-Filloy, J. A.; Gómez-Vaquero, C.; Fernández-Gutiérrez, B.; Balsa, A.; González-Álvaro, I.; Blanco, R.; Llorce, J.; Martín, J.; Gonzalez-Gay, M. A. Infl uence of MHCIITA rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2012; 30(1): 51-57. Article. 2,655  Q2
2012 García-Bermúdez, M.; López-Mejías, R.; González-Juanatey, C.; Corrales, A.; Castañeda, S.; Miranda-Filloy, J. A.; Gómez-Vaquero, C.; Fernández-Gutiérrez, B.; Balsa, A.; Pascual-Salcedo, D.; Blanco, R.; González-Álvaro, I.; Llorca, J.; Martín, J.; Gonzalez-Gay, M. A. Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients. DNA AND CELL BIOLOGY. 2012; 31(8): 1412-1417. Article. 2,344  Q3
2012 García-Bermúdez, M.; López-Mejías, R.; González-Juanatey, C.; Castañeda, S.; Miranda-Filloy, J. A.; Blanco, R.; Fernández-Gutiérrez, B.; Balsa, A.; González-Álvaro, I.; Gómez-Vaquero, C.; Llorca, J.; Martín, J.; González-Gay, M. A. Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. DNA AND CELL BIOLOGY. 2012; 31(7): 1214-1220. Article. 2,344 Q3
2012 López-Mejías, R.; García-Bermúdez, M.; González-Juanatey, C.; Castañeda, S.; Miranda-Filloy, J. A.; Gómez-Vaquero, C.; Fernández-Gutiérrez, B.; Balsa, A.; Pascual-Salcedo, D.; Blanco, R.; González-Álvaro, I.; Llorca, J.; Martín, J.; González-Gay, M. A. Lack of association between the CXCL12 rs501120 polymorphism and cardiovascular disease in Spanish patients with rheumatoid arthritis. HUMAN IMMUNOLOGY. 2012; 73(5): 543-546. Article.  2,298 Q3
2012 Michou, L.; Cornelis, F.; Levesque, J. M.; Bombardieri, S.; Balsa, A.; Westhovens, R.; Barrera, P.; Alves, H.; van de Putte, L.; Migliorini, P.; Bardin, T.; Petit-Teixeira, E.; Fernandes, M. J. G. A genetic association study of the CLEC12A gene in rheumatoid arthritis. JOINT BONE SPINE. 2012; 79(5): 451-456. Article.  2,748 Q2
2012 Carmona, F. D.; Serrano, A.; Rodríguez-Rodríguez, L.; Callejas, J. L.; Simeón, C. P.; Carreira, P.; Castañeda, S.; Solans, R.; Blanco, R.; González-Gay, M. A.; Martín, J. (de Miguel, E.). Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis. JOURNAL OF RHEUMATOLOGY. 2012; 39(6): 1275-1279. Article. 3,258 Q2
2012 Robledo, G.; González-Gay, M. A.; Fernández-Gutiérrez, B.; Lamas, J. R.; Balsa, A.; Pascual-Salcedo, D.; Castañeda, S.; Blanco, R.; González-Álvaro, I.; García, A.; Raya, E.; Gómez-Vaquero, C.; Delgado, M.; Martín, J. NPSR1 geneis associated with reduced risk of rheumatoid arthritis. JOURNAL OF RHEUMATOLOGY. 2012; 39(6): 1166-1170. Article. 3,258 Q2
2012 Puig, J. G.; Torres, R. J.; de Miguel, E.; Sánchez, A.; Bailén, R.; Banegas, J. R. Uric acid excretion in healthy subjects: a nomogram to assess the mechanisms underlying purine metabolic disorders. METABOLISM-CLINICAL AND EXPERIMENTAL. 2012; 61(4): 512-518. Article.  3,096 Q2
2012 García-Bermúdez, M.; López-Mejías, R.; González-Juanatey, C.; Corrales, A.; Robledo, G.; Castañeda, S.; Miranda-Filloy, J. A.; Blanco, R.; Fernández-Gutiérrez, B.; Balsa, A.; González-Álvaro, I.; Gómez-Vaquero, C.; Llorca, J.; Martín, J.; González-Gay, M. A. Analysis of the interferon gamma (rs2430561,+874T/A) functional gene variant in relation to the presence of cardiovascular events in rheumatoid arthritis. PLOS ONE. 2012; 7(10): e47166. Article.  3,73  Q1
2012 Arroyo-Villa, I.; Bautista-Caro, M. B.; Balsa, A.; Aguado-Acín, P.; Nuno, L.; Bonilla-Hernán, M. G.; Puig-Kroer, A.; Martín-Mola, E.; Miranda-Carús, M. E. Frequency of Th17 CD4+T cells in early rheumatoid arthritis: a marker of anti-CCP seropositivity. PLOS ONE. 2012; 7(8): e42189. Article. 3,73. Q1
2012 Benito-Miguel, M.; García-Carmona, Y.; Balsa, A.; Bautista-Caro, M. B.; Arroyo-Villa, I.; Cobo-Ibáñez, T.; Bonilla-Hernán, M. G.; de Ayala, C. P.; Sánchez-Mateos, P.; Martín-Mola, E.; Miranda-Carús, M. E. IL-15 expression on RA synovial fi broblasts promotes B cell survival. PLOS ONE. 2012; 7(7): e40620. Article. 3,73 Q1
2012 García-Bermúdez, M.; González-Juanatey, C.; López-Mejías, R.; Teruel, M.; Corrales, A.; Miranda-Filloy, J. A.; Castañeda, S.; Balsa, A.; Fernández-Gutiérrez, B.; González-Álvaro, I.; Gómez-Vaquero, C.; Blanco, R.; Llorca, J.; Martín, J.; González-Gay, M. A. Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in spanish rheumatoid arthritis patients. PLOS ONE. 2012; 7(11): e49214. Article.  3,73 Q1
2012 Lamana, A.; Balsa, A.; Rueda, B.; Ortiz, A. M.; Nuno, L.; Miranda-Carús, M. E.; González-Escribano, M. F.; López-Nevot, M. A.; Pascual-Salcedo, D.; Martín, J.; González-Álvaro, I. The TT genotype of the STAT4 rs7574865 polymorphism is associated with high disease activity and disability in patients with early arthritis. PLOS ONE. 2012; 7(8): e43661. Article. 3,73 Q1
2012 García-Bermúdez, M.; López-Mejías, R.; González-Juanatey, C.; Castañeda, S.; Miranda-Filloy, J. A.; Blanco, R.; Fernández-Gutiérrez, B.; Balsa, A.; González-Álvaro, I.; Gómez-Vaquero, C.; Llorca, J.; Martín, J.; González-Gay, M. A. Association of the methionine sulfoxide reductase a rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis. SCANDINAVIAN JOURNAL OF
RHEUMATOLOGY. 2012; 41(5): 350-353. Article.
2,216  Q3
2012 Cáliz, R.; del Amo, J.; Balsa, A.; Blanco, F.; Silva, L.; Sanmartí, R.; Martínez, F. G.; Collado, M. D.; Ramírez, M. D.; Tejedor, D.; Artieda, M.; Pascual-Salcedo, D.; Oreiro, N.; Andréu, J. L.; Graell, E.; Simón, L.; Martínez, A.; Mulero, J. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a spanish rheumatoid arthritis population. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2012; 41(1): 10-14. Article. 2,216  Q3
2012 Díaz-Gallo, L. M.; García, S.; Ortego-Centeno, N.; Jiménez-
Alonso, J.; Sánchez-Román, J.; de Ramón, E.; González-Escribano,
M. F.; Balsa, A.; Fernández-Gutiérrez, B.; González-Álvaro, I.; González-Gay, M. A.; Martín, J. Association study of BAK1 gene polymorphisms in spanish rheumatoid arthritis and systemic lupus erythematosus cohorts. ANNALS OF THE RHEUMATIC DISEASES. 2012; 71(2): 314-316.
Letter.
9,111 D1
2012 Chen-Xu, M.; Topless, R.; McKinney, C.; Merriman, M. E.; Phipps-Green, A.; Dalbeth, N.; Gow, P. J.; Harrison, A. A.; Highton, J.; Jones, P. B.; Nissen, M.; Smith, M. D.; van Rij, A.; Jones, G. T.; Rodríguez-Rodríguez, L.; Fernández-Gutiérrez, B.; Teruel, M.; Balsa, A.; Pascual-Salcedo, D.; Ortiz, A. M.; González-Gay, M. A.; Steer, S.; Maehlen, M.; Lie, B.; Wordsworth, B. P.; Stamp, L. K.; Martín, J.; Merriman, T. R. Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in caucasian sample sets. ANNALS OF THE RHEUMATIC DISEASES. 2012; 71(1): 155-157. Letter. 9,111 D1
2012 Torres, R. J.; de Miguel, E.; Bailén, R.; Puig, J. G. Absence of SLC22A12/URAT1 gene mutations in patients with primary gout. JOURNAL OF RHEUMATOLOGY. 2012; 39(9): 1901-1902.
Letter.
3,258 Q2
2012 Ash, Z. R.; Tinazzi, I.; Castillo-Gallego, C.; Kwok, C.; Wilson, C.; Goodfi eld, M.; Gisondi, P.; Tan, A. L.; Marzo-Ortega, H.; Emery, P.; Wakefi eld, R. J.; McGonagle, D. G.; Aydin, S. Z. Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. ANNALS OF THE RHEUMATIC DISEASES. 2012; 71(4): 553-556. Article. 9,111  D1
2012 Mandl, P.; Balint, P. V.; Brault, Y.; Backhaus, M.; D’Agostino, M. A.; Grassi, W.; van der Heijde, D.; de Miguel, E.; Wakefield, R. J.; Logeart, I.; Dougados, M. Metrologic properties of ultrasound versus clinical evaluation of synovitis in rheumatoid arthritis. ARTHRITIS AND RHEUMATISM. 2012; 64(4): 1272-1282. Article. 7,477 Q1
2012 de Agustín, J. J.; Moragues, C.; de Miguel, E.; Moller, I.; Acebes, C.; Naredo, E.; Usón, J.; Rejón, E.; Mayordomo, L.; Garrido, J. A multicentre study on high-frequency ultrasound evaluation of the skin and joints in patients with psoriatic arthritis treated with infl iximab. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2012; 30(6): 879-885. Article. 2,655 Q2
2012 de Miguel, E.; Roxo, A.; Castillo, C.; Peiteado, D.; Villalba, A.; Martín-Mola, E. The utility and sensitivity of colour doppler ultrasound in monitoring changes in giant cell arteritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2012; 30(1): s34-s38. Article. 2,655 Q2
2012 Peiteado, D.; de Miguel, E.; Villalba, A.; Ordóñez, M. C.; Castillo,
C.; Martín-Mola, E. Value of a short four-joint ultrasound test for gout diagnosis: a pilot study. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2012; 30(6): 830-837. Article.
2,655 Q2
2012 Aydin, S. Z.; Castillo-Gallego, C.; Ash, Z. R.; Marzo-Ortega, H.; Emery, P.; Wakefi eld, R. J.; Wittmann, M.; McGonagle, D. Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal interphalangeal joint extensor tendon enthesopathy. DERMATOLOGY. 2012; 225(3): 231-235. Article. 2,024  Q2
2012 de Miguel, E.; Andréu, J. L.; Naredo, E.; Moller, I. Situation of spanish echography in spanish rheumatology 2012. REUMATOLOGÍA CLÍNICA. 2012; 8(6): 310-314. Article. N/A N/A
2012 Lojo Oliveira, L.; Torrijos Eslava, A. Treatment of Paget’s disease
of bone. REUMATOLOGÍA CLÍNICA. 2012; 8(4): 220-224. Article.
N/A N/A
2012 de Miguel, E.; Andréu, J. L.; Naredo, E.; Möller, I. Grupo de Trabajo de Ecografía de la Sociedad Española de Reumatología (ECOSER). Situation of spanish echography in spanish rheumatology 2012. REVISTA ESPAÑOLA DE REUMATOLOGÍA. 2012; 8(6): 310-314. Article. N/A N/A
2012 Mandl, P.; Naredo, E.; Conaghan, P. G.; D’Agostino, M. A.; Wakefi eld, R. J.; Bachta, A.; Backhaus, M.; Hammer, H. B.; Bruyn, G. A. W.; Damjanov, N.; Filippucci, E.; Grassi, W.; Iagnocco, A.; Jousse-Joulin, S.; Kane, D.; Koski, J. M.; Moller, I.; de Miguel, E.; Schmidt, W. A.; Swen, W. A. A.; Szkudlarek, M.; Terslev, L.; Ziswiler, H. R.; Ostergaard, M.; Balint, P. V. Practice of ultrasound-guided arthrocentesis and joint injection, including training and implementation, in Europe: results of a survey of experts and scientifi c societies. RHEUMATOLOGY. 2012; 51(1): 184-190. Article. 4,212 Q1
2012 Miguel, C.; de Miguel, E.; Batlle-Gualda, E.; Rejón, E.; Lojo, L. Teaching enthesis ultrasound: experience of an ultrasound training workshop. RHEUMATOLOGY INTERNATIONAL. 2012; 32(12): 4047-4052. Article. 2,214 Q3
2012 de Miguel, E.; Puig, J. G.; Castillo, C.; Peiteado, D.; Torres, R. J.; Martín-Mola, E. Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study. ANNALS OF THE RHEUMATIC DISEASES. 2012; 71(1): 157-158. Letter. 9,111  D1
2012 Falcao, S.; de Miguel, E.; Castillo, C.; Branco, J. C.; Martín-Mola, E. Doppler ultrasound - a valid and reliable tool to assess spondyloarthritis. ACTA REUMATOLOGICA PORTUGUESA. 2012; 37(3): 212-217. Review. 0,695 Q4
2012 Wakefield, R. J.; D’Agostino, M. A.; Naredo, E.; Buch, M.H.; Iagnocco, A.; Terslev, L.; Ostergaard, M.; Backhaus, M.; Grassi, W.; Dougados, M.; Burmester, G. R.; Saleem, B.; de Miguel, E.; Estrach, C.; Ikeda, K.; Gutiérrez, M.; Thompson, R.; Balint, P.; Emery, P . After treat-to-target: can a targeted ultrasound initiative improve RA outcomes? ANNALS OF THE RHEUMATIC DISEASES. 2012; 71(6): 799-803. Review.  9,111 D1
2012 Wakefi eld, R. J.; D’Agostino, M. A.; Naredo, E.; Buch, M.H.; Iagnocco, A.; Terslev, L.; Ostergaard, M.; Backhaus, M.; Grassi, W.; Dougados, M.; Burmester, G. R.; Saleem, B.; de Miguel, E.; Estrach, C.; Ikeda, K.; Gutiérrez, M.; Thompson, R.; Balint, P.; Emery, P. After treat-to-target: can a targeted ultrasound initiative improve RA outcomes? POSTGRADUATE MEDICAL JOURNAL. 2012; 88(1042): 482-486. Review. 1,608 Q2
2012 de Miguel Mendieta, E.; Castillo Gallego, C. Present and future of echography in spondyloarthritis. REUMATOLOGÍA CLÍNICA. 2012; 8(Suppl. 1): s32-s36. Review. N/A N/A
2012 Díez-Pérez, A.; Olmos, J. M.; Nogues, X.; Sosa, M.; Díaz-Curiel, M.; Pérez-Castrillón, J. L.; Pérez-Cano, R.; Muñoz-Torres, M.; Torrijos, A.; Jodar, E.; del Río, L.; Caeiro-Rey, J. R.; Farrerons, J.; Vila, J.; Arnaud, C.; González-Macías, J. Risk factors for prediction of inadequate response to antiresorptives. JOURNAL OF BONE AND MINERAL RESEARCH. 2012; 27(4): 817-824. Article. 6,128 Q1
2011 Haraoui, B.; Smolen, J. S.; Aletaha, D.; Breedveld, F. C.; Burmester G.; Codreanu, C.; Da Silva, J. P.; de Wit, M.; Dougados, M.; Durez, P.; Emery, P.; Fonseca, J. E.; Gibofsky, A.; Gómez-Reino, J.; Graninger, W.; Hamuryudan, V.; Pena, M. J. J.; Kalden, J.; Kvien, T. K.; Laurindo, I.; Martín-Mola, E.; Montecucco, C.; Moreno, P. S.; Pavelka, K.; Poor, G.; Cardiel, M. H.; Stanislawska-Biernat, E.; Takeuchi, T.; van der Heijde, D. Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(11): 1999-2002. 8,727 D1
2011 Buch, M. H.; Smolen, J. S; Betteridge, N.; Breedveld, F. C.; Burmester,
G.; Dorner, T.; Ferraccioli, G.; Gottenberg, J. E.; Isaacs, J.; Kvien, T. K.; Mariette, X.; Martín-Mola, E.; Pavelka, K.; Tak, P. P.; van der Heijde, D.; van Vollenhoven, R. F; Emery, P. Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(6): 909-920. Review.
8,727 D1
2011 Felson, D. T.; Smolen, J. S.; Wells, G.; Zhang, B.; van Tuyl, L. H. D.;
Funovits, J.; Aletaha, D.; Allaart, C. F.; Bathon, J.; Bombardieri, S.;
Brooks, P.; Brown, A.; Matucci-Cerinic, M.; Choi, H.; Combe, B.;
de Wit, M.; Dougados, M.; Emery, P.; Furst, D.; Gómez-Reino,
J.; Hawker, G. American College of Rheumatology, European
League Against Rheumatism Provisional Definition of Remission
in Rheumatoid Arthritis for Clinical Trials. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(3): 404-413. Article.
8,727 D1
2011 Gossec, L.; Bijlsma, J. W. J.; Bombardier, C.; Canhao, H.; Devlin,
J.; Edwards, C. J.; Hamuryudan, V.; Kvien, T. K.; Leeb, B. F.; Martín-
Mola, E. M.; Mielants, H.; Muller-Ladner, U.; Ostergaard, M.; Pereira,
I. A.; Ramos-Remus, C.; Zochling, J.; Dougados, M. Dissemination
and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(2): 388-U180. Letter.
8,727 D1
2011 Machado, P.; Castrejón, I.; Katchamart, W.; Koevoets, R.; Kuriya,
B.; Schoels, M.; Silva-Fernández, L.; Thevissen, K.; Vercoutere, W.;
Villeneuve, E.; Aletaha, D.; Carmona, L.; Landewe, R.; van der Heijde,
D.; Bijlsma, J. W. J.; Bykerk, V.; Canhao, H.; Catrina, A. I.; Durez, P. Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(1): 15-24. Review.
8,727 D1
2011 García-Arias, M.; Balsa, A.; Mola, E. M. Septic arthritis. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY. 2011; 25(3): 407-421. Article. 2,653 Q2
2011 Navarro-Sarabia, F.; Fernández-Sueiro, J. L.; Torre-Alonso, J. C.;
Gratacos, J.; Queiro, R.; González, C.; Loza, E.; Linares, L.; Zarco, P.; Juanola, X.; Roman-Ivorra, J.; Martín-Mola, E.; Sanmarti, R.; Mulero,
J.; Díaz, G.; Armendáriz, Y.; Collantes, E. High-dose etanercept in ankylosing spondylitis: results of a 12-week randomized, double blind, controlled multicentre study (LOADET study). RHEUMATOLOGY.
2011; 50(10): 1828-2837. Article.
4,058 Q2
2011 Pascual-Salcedo, D.; Plasencia, C.; Ramiro, S.; Nuno, L.; Bonilla, G.;
Nagore, D.; del Agua, A. R.; Martínez, A.; Aarden, L.; Martín-Mola, E.;
Balsa, A. Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis. RHEUMATOLOGY. 2011; 50(8): 1445-1452. Article.
4,058 Q2
2011 Martín-Mola, E.; Gómez-Carrera, L. The impact of a jointly staffed
clinic on the diagnosis of lung involvement and connective tissue diseases. RHEUMATOLOGY. 2011; 50(3): 434-436. Editorial Material.
4,058 Q2
2011 Gossec, L.; Paternotte, S.; Aanerud, G. J.; Balanescu, A.; Boumpas, D.
T.; Carmona, L.; de Wit, M.; Dijkmans, B. A. C.; Dougados, M.; Englbrecht, M.; Gogus, F.; Heiberg, T.; Hernandez, C.; Kirwan, J. R.; Mola, E. M.; Cerinic, M. M.; Otsa, K.; Schett, G.; Scholte-Voshaar, M.; Sokka, T.; von Krause, G.; Wells, G. A.; Kvien, T. K. Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(6): 935-942. Article.
8,727 D1
2011 Burmester, G.; Lanas, A.; Biasucci, L.; Hermann, M.; Lohmander, S.;
Olivieri, I.; Scarpignato, C.; Smolen, J.; Hawkey, C.; Bajkowski, A.; Berenbaum, F.; Breedveld, F.; Dieleman, P.; Dougados, M.; MacDonald, T.; Mola, E. M.; Mets, T.; Van den Noortgate, N.; Stoevelaar, H. The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(5): 818-822. Article.
8,727 D1
2011 Felson, D. T.; Smolen, J. S.; Wells, G.; Zhang, B.; van Tuyl, L. H.. D.; Funovits, J.; Aletaha, D.; Allaart, C. F.; Bathon, J.; Bombardieri, S.; Brooks, P.; Brown, A.; Matucci-Cerinic, M.; Choi, H.; Combe, B.; de Wit, M.; Dougados, M.; Emery, P.; Furst, D.; Gómez-Reino, J.; Hawker, G. American College of Rheumatology, European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials ARTHRITIS AND RHEUMATISM. 2011; 63(3): 573-586. Article. 7,866 Q1
2011 Bonilla-Hernán, M. G.; Miranda-Carús, M. E.; Martín-Mola, E. New
drugs beyond biologics in rheumatoid arthritis: the kinase inhibitors.
RHEUMATOLOGY. 2011; 50(9): 1542-1550. Review.
4,058 Q2
2011 Varade, J.; Palomino-Morales, R.; Ortego-Centeno, N.; Díaz-Rubio,
M.; Fernández-Gutiérrez, B.; González-Gay, M. A.; Pascual-Salcedo,
D.; Balsa, A.; Iglesias, A.; Gómez-García, M.; Witte, T.; Radstake, T. R.
D. J.; Coenen, M. J. H.; Urcelay, E.; Martín, J. Analysis of the REL polymorphism rs13031237 in autoimmune diseases. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(4): 711-U206. Letter.
8,727 D1
2011 Dawidowicz, K.; Allanore, Y.; Guedj, M.; Pierlot, C.; Bombardieri, S.;
Balsa, A.; Westhovens, R.; Barrera, P.; Alves, H.; Teixeira, V. H.; Petit-
Teixeira, E.; van de Putte, L.; van Riel, P.; Prum, B.; Bardin, T.; Meyer,
O.; Cornelis, F.; Dieude, P (Pascuale-Salcedo, D.; Balsa, A.). The interferon regulatory factor 5 gene confers susceptibility to rheumatoid
arthritis and influences its erosive phenotype. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(1): 117-121. Article.
8,727 D1
2011 Rodríguez-Rodríguez, L.; Taib, W. R. W.; Topless, R.; Steer, S.; González-Escribano, M. F.; Balsa, A.; Pascual-Salcedo, D.; González-Gay, M.A.; Raya, E.; Fernández-Gutiérrez, B; González-Álvaro, I.; Bottini, N.; Witte, T.; Viken, M. K.; Coenen, M. J. H.; van Riel, P. L. C. M. ; Franke, B. The PTPN22 R263Q Polymorphism Is a Risk Factor for Rheumatoid Arthritis in Caucasian Case-Control Samples. ARTHRITIS AND RHEUMATISM. 2011; 63(2): 365-372. Article. 7,866 Q1
2011 Teruel, M.; Martín, J. E.; González-Juanatey, C.; López-Mejías, R.; Miranda-Filloy, J. A.; Blanco, R.; Balsa, A.; Pascual-Salcedo, D.; Rodríguez-Rodríguez, L.; Fernández-Gutiérrez, B.; Ortiz, A. M.; González-Álvaro, I.; Gómez-Vaquero, C.; Bottini, N.; Llorca, J.; González-Gay, M. A.; Martín, J. Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients. ARTHRITIS RESEARCH & THERAPY. 2011; 13(4): R116. Article. 4,445 Q1
2011 García-Bermúdez, M.; González-Juanatey, C.; Rodríguez-Rodríguez,
L.; Miranda-Filloy, J. A.; Pérez-Esteban, S.; Vázquez-Rodríguez, T. R.;
Castaneda, S.; Balsa, A.; Fernández-Gutiérrez, B.; Llorca, J.; González-
Álvaro, I.; Martín, J.; González-Gay, M. A. Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2011; 29(4):681-688. Article.
2,148 Q3
2011 Martín, J. E.; Alizadeh, B. Z.; González-Gay, M. A.; Balsa, A.; Pascual-
Salcedo, D.; González-Escribano, M. F.; Rodríguez-Rodríguez, L.;
Fernández-Gutiérrez, B.; Raya, E.; Coenen, M. J. H.; van Riel, P.; Radstake, T. R. D. J.; Kvien, T. K.; Viken, M. K.; Lie, B. A.; Koeleman, B. P. C.; Martín, J. Evidence for PTPN22 R620W Polymorphism As the Sole Common Risk Variant for Rheumatoid Arthritis in the 1p13.2 Region. JOURNAL OF RHEUMATOLOGY. 2011; 38(11): 2290-2296. Article.
3,695 Q2
2011 López-Mejías, R.; García-Bermúdez, M.; González-Juanatey, C.; Castaneda, S.; Miranda-Filloy, J. A.; Gómez-Vaquero, C.; Fernández-Gutiérrez, B.; Balsa, A.; Pascual-Salcedo, D.; Blanco, R.; González-Álvaro, I.; Llorca, J.; Martín, J.; González-Gay, M. A. Lack of association of IL6R rs2228145 and IL6ST/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis. TISSUE ANTIGENS. 2011; 78(6): 438-441. Article. 2,588 Q2
2011 de Miguel, E.; Falcao, S.; Castillo, C.; Plasencia, C.; García, M.; Branco, J. C.; Martín-Mola, E. Enthesis erosion in spondyloarthritis is not a persistent structural lesion. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(11): 2008-2010. Article. 8,727 D1
2011 de Miguel, E.; Muñoz-Fernández, S.; Castillo, C.; Cobo-Ibáñez, T.;
Martín-Mola, E. Diagnostic accuracy of enthesis ultrasound in the diagnosis of early spondyloarthritis. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(3): 434-439. Article.
8,727 D1
2010 Muñoz-Fernández.; S.; de Miguel.; E.; Cobo-Ibáñez.; T.; Carmona.; L.; Steiner.; M.; Descalzo.; M. A.; Ferreira.; A.; Balsa.; A.; Martín-Mola.; E. Early spondyloarthritis: results from the pilot registry ESPIDEP. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2010.; 28(4): 498-503. Article. 2,358 Q3
2010 Martín-Mola.; E.; Sieper.; J.; Leirisalo-Repo.; M.; Dijkmans.; B. A. C.; Vlahos.; B.; Pedersen.; R.; Koenig.; A. S.; Freundlich.; B. Sustained efficacy and safety.; including patient-reported outcomes.; with etanercept treatment over 5 years in patients with ankylosing spondylitis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2010.; 28(2): 238-245. Article. 2,358 Q3
2010 Balsa.; A.; Cabezón.; A.; Orozco.; G.; Cobo.; T.; Miranda-Carús.; E.; López-Nevot.; M. A.; Vicario.; J. L.; Martín-Mola.; E.; Martín.; J.; Pascual-Salcedo.; D. Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor. ARTHRITIS RESEARCH & THERAPY. 2010.; 12(2): R62. Article. 4,357 Q2
2010 Schoels, M.; Knevel, R.; Aletaha, D.; Bijlsma, J. W.; Breedveld, F. C.; Boumpas, D. T.; Burmester, G.; Combe, B.; Cutolo, M.; Dougados, M.; Emery, P.; van der Heijde, D.; Huizinga .T. W.; Kalden, J.; Keystone, E. C.; Kvien, T. K.; Martín-Mola, E.; Montecucco, C.; de Wit, M.; Smolen, J. S. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. ANNALS OF THE RHEUMATIC DISEASES. 2010; 69(4): 638-643. Article. 9,082 Q1
2010 Balsa, A.;. de Miguel, E.; Castillo, C.; Peiteado, D.; Martín-Mola, E.. Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard. RHEUMATOLOGY . 2010; 49(4): 683-690. Article. 4,171 Q2
2010 Conaghan, P. G.; D’Agostino, M. A.; Le Bars, M.; Baron, G.; Schmidely, N.; Wakefield, R.; Ravaud, P.; Grassi ,W.; Martín-Mola, E.; So, A.; Backhaus, M.; Malaise, M.; Emery, P.; Dougados, M. Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large.; 3-year.; prospective EULAR study. ANNALS OF THE RHEUMATIC DISEASES. 2010; ;69(4): 644-647. Article. 9,082 Q1
2010 Schoels, M.; Aletaha, D.; Smolen, J. S.; Bijlsma, J. W.; Burmester, G.; Breedveld, F. C.; Cutolo, M.; Combe B.; Dougados, M.; Emery, P.; Kalden, J.; Keystone, E. C.; Kvien, T. K.; Martín-Mola, E.; Montecucco, C.; De Wit, M. Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008. ANNALS OF THE RHEUMATIC DISEASES. 2010; 69(3): 575-578. Article. 9,082 Q1
2010 Palomino-Morales, R.; González-Juanatey, C.; Vázquez-Rodríguez, T. R.; Rodríguez, L.; Miranda-Filloy, J. A.; Pascual-Salcedo, D.; Balsa, A.; Fernández-Gutierrez, B.; Llorca, J.; Martín, J.; González-Gay, M. A. Lack of association of PTPN22.; STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2010; 28(5): 695-701. Article. 2,358 Q3
2010 Martín, J. E.; Alizadeh, B. Z.; González-Gay, M. A.; Balsa, A.; Pascual-Salcedo, D.; Fernández-Gutiérrez, B.; Raya, E.; Franke, L.; van’t Slot, R.; Coenen, M. J.; van Riel, P.; Radstake, T. R.; Koeleman, B. P.; Martín, J. Identification of the oxidative stress-related gene MSRA as a rheumatoid arthritis susceptibility locus by genome-wide pathway analysis. ARTHRITIS AND RHEUMATISM. 2010; 62(11): 3183-3190. Article. 8,345 Q1
2010 Alonso, A.; Julià, A.; Tortosa, R.; Canaleta, C.; Cañete, J. D.; Ballina, J.; Balsa, A.; Tornero, J.; Marsal, S. CNstream: a method for the identification and genotyping of copy number polymorphisms using Illumina microarrays. BMC BIOINFORMATICS. 2010; 11: 264. Article. 3,028 Q1
2010 Robledo, G.; Rueda, B.; González-Gay, M. A.; Fernández, B.; Lamas, J. R.; Balsa, A.; Pascual-Salcedo, D.; García, A.; Raya, E.; Martín, J. Association study of ghrelin receptor gene polymorphisms in rheumatoid arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2010; 28(1): 25-29. Article. 2,358 Q3
2010 Docampo, E.; Rabionet, R.; Riveira-Muñoz, E.; Escaramís, G.; Julià, A.; Marsal, S.; Martín, J. E.; González-Gay, M. A.; Balsa, A.; Raya, E.; Martín, J.; Estivill, X. Deletion of the late cornified envelope genes.; LCE3C and LCE3B.; is associated with rheumatoid arthritis. ARTHRITIS AND RHEUMATISM. 2010; 62(5): 1246-1251. Article. 8,345 Q1
2010 Perdigones, N.; Vigo, A. G.; Lamas, J. R.; Martínez, A.; Balsa, A.; Pascual-Salcedo, D.; de la Concha, E. G.; Fernández-Gutiérrez, B.; Urcelay, E. Evidence of epistasis between TNFRSF14 and TNFRSF6B polymorphisms in patients with rheumatoid arthritis. ARTHRITIS AND RHEUMATISM. 2010; 62(3): 705-710. Article. 8,345 Q1
2010 van der Woude, D.; Lie, B. A.; Lundström, E.; Balsa, A.; Feitsma, A. L.; Houwing-Duistermaat, J. J.; Verduijn, W.; Nordang, G. B.; Alfredsson, L.; Klareskog, L.; Pascual-Salcedo, D.; González-Gay, M. A.; López-Nevot, M. A.; Valero, F.; Roep, B. O.; Huizinga, T. W,.; Kvien, T. K.; Martín, J.; Padyukov, L.; de Vries, R. R.; Toes, R. E. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations. ARTHRITIS AND RHEUMATISM. 2010; 62(5): 1236-1245. Article. 8,345 Q1
2010 Balsa, A.; Del Amo, J.; Blanco, F.; Caliz, R.; Silva, L.; Sanmartí, R.; Martínez, F. G.; Tejedor, D.; Artieda, M.; Pascual-Salcedo, D.; Oreiro, N.; Collado, M. D.; Andreu, J. L.; Graell, E.; Simón, L.; Martínez, A.; Mulero, J. Prediction of functional impairment and remission in rheumatoid arthritis patients by biochemical variables and genetic polymorphisms. RHEUMATOLOGY. 2010; 49(3): 458-466. Article. 4,171 Q2
2010 Silva, L.; Miguel, E. D.; Peiteado, D.; Villalba, A.; Mola, M.; Pinto, J.; Ventura, F. S. Compliance in gout patients. ACTA REUMATOLOGICA PORTUGUESA. 2010; 35(5): 466-474. Article. 0,451 Q4
2010 Ozen, S.; Pistorio, A.; Iusan, S. M.; Bakkaloglu, A.; Herlin, T.; Brik, R.; Buoncompagni, A.; Lazar, C.; Bilge, I.; Uziel, Y.; Rigante, D.; Cantarini, L.; Hilário, M. O.; Silva, C. A.; Alegria, M.; Norambuena, X.; Belot, A.; Berkun, Y.; Estrella, A. I.; Olivieri, A. N.; Alpigiani, M. G.; Rumba, I.; Sztajnbok, F.; Tambic-Bukovac L.; Breda L.; Al-Mayouf S.; Mihaylova D.; Chasnyk V.; Sengler C.; Klein-Gitelman M.; Djeddi D.; Nuno L.; Pruunsild C.; Brunner J.; Kondi A.; Pagava K.; Pederzoli S.; Martíni A.; Ruperto N.; Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura.; childhood polyarteritis nodosa.; childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. ANNALS OF THE RHEUMATIC DISEASES. 2010; 69(5): 798-806. Article. 9,082 Q1
2010 Naredo, E.; Möller, I.; Acebes, C.; Batlle-Gualda, E.; Brito, E.; de Agustín, J. J.; de Miguel, E.; Martínez, A.; Mayordomo, L.; Moragues, C.; Rejón, E.; Rodríguez, A.; Uson, J.; Garrido, J. Three-dimensional volumetric ultrasonography. Does it improve reliabililty of musculoskeletal ultrasound? CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2010; 28(1): 79-82. Article. 2,358
Q3
2010 Fraile, J. M.; Puig, J. G.; Torres, R. J.; de Miguel, E.; Martínez, P.; Vázquez, J. J. Uric acid metabolism in patients with primary gout and the metabolic syndrome. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS. 2010; 29: 330-334. Article. 1,132
Q4
2010 Fraile, J. M.; Torres, R.; de Miguel Mendieta, E.; Martínez, P.; Lundelin, K. J.; Vázquez, J. J.; Puig, J. G. Metabolic syndrome characteristics in gout patients. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS. 2010; 29: 325-329. Article. 1,132 Q4
2010 Smolen, J. S.; Landewé, R.; Breedveld, F. C.; Dougados, M.; Emery, P.; Gaujoux-Viala, C.; Gorter, S.; Knevel, R.; Nam, J.; Schoels, M.; Aletaha, D.; Buch, M.; Gossec, L.; Huizinga, T.; Bijlsma, J. W.; Burmester, G.; Combe, B.; Cutolo, M.; Gabay, C.; Gómez-Reino, J.; Kouloumas, M.; Kvien, T. K.; Martín-Mola, E.; McInnes, I.; Pavelka, K.; van Riel, P.; Scholte, M.; Scott, D. L.; Sokka, T.; Valesini, G.; van Vollenhoven, R.; Winthrop, K. L.; Wong, J.; Zink, A.; van der Heijde, D. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. ANNALS OF THE RHEUMATIC DISEASES. 2010.; 69(6): 964-975. Review. 9,082 Q1
2010 Smolen, J. S.; Aletaha, D.; Bijlsma, J. W.; Breedveld, F. C.; Boumpas, D.; Burmester, G.; Combe, B.; Cutolo, M.; de Wit, M.; Dougados, M.; Emery, P.; Gibofsky, A.; Gómez-Reino, J. J.; Haraoui, B.; Kalden, J.; Keystone, E. C.; Kvien, T. K.; McInnes, I.; Martín-Mola, E.; Montecucco, C.; Schoels, M.; van der Heijde D.; T2T Expert Committee. Treating rheumatoid arthritis to target: recommendations of an international task force. ANNALS OF THE RHEUMATIC DISEASES. 2010; 69(4): 631-637. Review. 9,082 Q1
2009 Falcao, S; Gamero, F; de Miguel, E; Mourao, AF; Pimentiao, JB; Branco, JC; Mola, EM. Foreign body reaction to palm leaf. ACTA REUMATOLOGICA PORTUGUESA. 2009; 34(1): 136-137 0,726
Q4
2009 Videira, T; De Miguel, E; Ventura, FS; Mola, EM. Hip arthritis in an young adult - a diagnosis to consider. ACTA REUMATOLOGICA PORTUGUESA. 2009; 34(4): 651-655 0,726
Q4
2009 Monteiro, P; de Miguel, E; Mola, EM. Musculoskeletal ultrasonography in rheumatology. ACTA REUMATOLOGICA PORTUGUESA. 2009; 34(2B): 388-394 0,726
Q4
2009 Teixeira, VH; Dieude, P; Michou, L; Migliorini, P; Balsa, A; Westhovens, R; Barrera, P; Alves, H; Vaz, C; Fernandes, M; Pascual-Salcedo, D; Bombardieri, S; Dequeker, J; Radstake, TR; Van Riel, P; van de Putte, L; Lopes-Vaz, A; Bardin, T; Cornelis, F; Petit-Teixeira, E. Association study of the RANK locus in white European rheumatoid arthritis families. ANNALS OF THE RHEUMATIC DISEASES. 2009; 68(3): 448-449 8,111
Q1
2009 Gossec, L; Dougados, M; Rincheval, N; Balanescu, A; Boumpas, DT; Canadelo, S; Carmona, L; Daures, JP; de Wit, M; Dijkmans, BAC; Englbrecht, M; Gunendi, Z; Heiberg, T; Kirwan, JR; Mola, EM; Matucci-Cerinic, M; Otsa, K; Schett, G; Sokka, T; Wells, GA; Aanerud, GJ; Celano, A; Dudkin, A; Hernandez, C; Koutsogianni, K; Akca, FN; Petre, AM; Richards, P; Scholte-Voshaar, M; Von Krause, G; Kvien, TK. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. ANNALS OF THE RHEUMATIC DISEASES. 2009; 68(11): 1680-1685 8,111
Q1
2009 Zhang, W; Doherty, M; Leeb, BF; Alekseeva, L; Arden, NK; Bijlsma, JW; Dincer, F; Dziedzic, K; Hauselmann, HJ; Kaklamanis, P; Kloppenburg, M; Lohmander, LS; Maheu, E; Martin-Mola, E; Pavelka, K; Punzi, L; Reiter, S; Smolen, J; Verbruggen, G; Watt, I; Zimmermann-Gorska, I. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. ANNALS OF THE RHEUMATIC DISEASES. 2009; 68(1): 8-17 8,111
Q1
2009 Dieguez-Gonzalez, R; Akar, S; Calaza, M; Perez-Pampin, E; Costas, J; Torres, M; Vicario, JL; Velloso, ML; Navarro, F; Narvaez, J; Joven, B; Herrero-Beaumont, G; Gonzalez-Alvaro, I; Fernandez-Gutierrez, B; de la Serna, AR; Carreno, L; Lopez-Longo, J; Caliz, R; Collado-Escobar, MD; Blanco, FJ; Fernandez-Lopez, C; Balsa, A; Pascual-Salcedo, D; Gomez-Reino, JJ; Gonzalez, A. Genetic variation in the nuclear factor kappa B pathway in relation to susceptibility to rheumatoid arthritis. ANNALS OF THE RHEUMATIC DISEASES. 2009; 68(4): 579-583 8,111
Q1
2009 van der Heijde, D; Burmester, G; Melo-Gomes, J; Codreanu, C; Mola, EM; Pedersen, R; Robertson, D; Chang, D; Koenig, A; Freundlich, B. Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy. ANNALS OF THE RHEUMATIC DISEASES. 2009; 68(7): 1113-1118 8,111
Q1
2009 Visser, K; Katchamart, W; Loza, E; Martinez-Lopez, JA; Salliot, C; Trudeau, J; Bombardier, C; Carmona, L; van der Heijde, D; Bijlsma, JWJ; Boumpas, DT; Canhao, H; Edwards, CJ; Hamuryudan, V; Kvien, TK; Leeb, BF; Martin-Mola, EM; Mielants, H; Muller-Ladner, U; Murphy, G; Ostergaard, M; Pereira, IA; Ramos-Remus, C; Valentini, G; Zochling, J; Dougados, M. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E. ANNALS OF THE RHEUMATIC DISEASES. 2009; 68(7): 1086-1093 8,111
Q1
2009 de Miguel, E; Cobo, T; Munoz-Fernandez, S; Naredo, E; Uson, J; Acebes, JC; Andreu, JL; Martin-Mola, E. Validity of enthesis ultrasound assessment in spondyloarthropathy. ANNALS OF THE RHEUMATIC DISEASES. 2009; 68(2): 169-174 8,111
Q1
2009 Munoz-Fernandez, S; de Miguel, E; Cobo-Ibanez, T; Madero, R; Ferreira, A; Hidalgo, MV; Schlincker, A; Martin-Mola, E. Enthesis Inflammation in Recurrent Acute Anterior Uveitis Without Spondylarthritis. ARTHRITIS AND RHEUMATISM. 2009; 60(7): 1985-1990 4,152
Q2
2009 Suarez-Gestal, M; Calaza, M; Dieguez-Gonzalez, R; Perez-Pampin, E; Pablos, JL; Navarro, F; Narvaez, J; Marenco, JL; Herrero-Beaumont, G; Fernandez-Gutierrez, B; Lamas, JR; de la Serna, AR; Ortiz, AM; Carreno, L; Canete, JD; Caliz, R; Blanco, FJ; Balsa, A; Gomez-Reino, JJ; Gonzalez, A. Rheumatoid Arthritis Does Not Share Most of the Newly Identified Systemic Lupus Erythematosus Genetic Factors. ARTHRITIS AND RHEUMATISM. 2009; 60(9): 2558-2564 4,152
Q2
2009 Rozco, G; Abelson, AK; Gonzalez-Gay, MA; Balsa, A; Pascual-Salcedo, D; Garcia, A; Fernandez-Gutierrez, B; Petersson, I; Pons-Estel, B; Eimon, A; Paira, S; Scherbarth, HR; Alarcon-Riquelme, M; Martin, J. Study of Functional Variants of the BANK1 Gene in Rheumatoid Arthritis. ARTHRITIS AND RHEUMATISM. 2009; 60(2): 372-379 4,152
Q2
2009 Dieguez-Gonzalez, R; Calaza, M; Perez-Pampin, E; Balsa, A; Blanco, FJ; Canete, JD; Caliz, R; Carreno, L; de la Serna, AR; Fernandez-Gutierrez, B; Ortiz, AM; Herrero-Beaumont, G; Pablos, JL; Narvaez, J; Navarro, F; Marenco, JL; Gomez-Reino, JJ; Gonzalez, A. Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappa B and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility. ARTHRITIS RESEARCH & THERAPY. 2009; 11(2): R42 4,271
Q1
2009 Sanmarti, R; Graell, E; Perez, ML; Ercilla, G; Vinas, O; Gomez-Puerta, JA; Gratacos, J; Balsa, A; Gomara, MJ; Larrosa, M; Canete, JD; Haro, I. Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis. ARTHRITIS RESEARCH & THERAPY. 2009; 11(5): R135 4,271
Q1
2009 Teixeira, VH; Pierlot, C; Migliorini, P; Balsa, A; Westhovens, R; Barrera, P; Alves, H; Vaz, C; Fernandes, M; Pascual-Salcedo, D; Bombardieri, S; Dequeker, J; Radstake, TR; Van Riel, P; van de Putte, L; Lopes-Vaz, A; Bardin, T; Prum, B; Cornelis, F; Petit-Teixeira, E. Testing for the association of the KIAA1109/Tenr/IL2/IL21 gene region with rheumatoid arthritis in a European family-based study. ARTHRITIS RESEARCH & THERAPY. 2009; 11(2): R45 4,271
Q1
2009 Munoz-Fernandez, S; Garcia-Aparicio, AM; Hidalgo, MV; Platero, M; Schlincker, A; Bascones, ML; Pombo, M; Morente, P; Sanpedro, J; Martin-Mola, E. Methotrexate: an option for preventing the recurrence of acute anterior uveitis. EYE. 2009; 23(5): 1130-1133 1,974
Q2
2009 Benito-Miguel, M; Garcia-Carmona, Y; Balsa, A; de Ayala, CP; Cobo-Ibanez, T; Martin-Mola, E; Miranda-Carus, ME. A Dual Action of Rheumatoid Arthritis Synovial Fibroblast IL-15 Expression on the Equilibrium between CD4(+)CD25(+) Regulatory T Cells and CD4(+)CD25(-) Responder T Cells. JOURNAL OF IMMUNOLOGY. 2009; 183(12): 8268-8279 5,646
Q1
2009 Dijkmans, B; Emery, P; Hakala, M; Leirisalo-Repo, M; Mola, EM; Paolozzi, L; Salvarani, C; Sanmarti, R; Sibilia, J; Sieper, J; Van den Bosch, F; van der Heijde, D; van der Linden, S; Wajdula, J. Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis. JOURNAL OF RHEUMATOLOGY. 2009; 36(6): 1256-1264 3,854
Q2
2009 Maillefert, JF; Kloppenburg, M; Fernandes, L; Punzi, L; Gunther, KP; Mola, EM; Lohmander, LS; Pavelka, K; Lopez-Olivo, MA; Dougados, M; Hawker, GA. Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP). OSTEOARTHRITIS AND CARTILAGE. 2009; 17(10): 1293-1296 3,888
Q1
2009 Martin-Mola, E; Balsa, A. Infectious Complications of Biologic Agents. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. 2009; 35(1): 183 2,594
Q2